Tempest Therapeutics (TPST) Treasury Shares (2011 - 2021)

Tempest Therapeutics has disclosed Treasury Shares across 7 years of filings, most recently posting $114.7 million for Q4 2021.

• In Q4 2021, Treasury Shares changed 0.0% year-over-year to $114.7 million; the TTM figure through Dec 2021 stood at $114.7 million (changed 0.0% YoY), while the FY2021 annual figure was $114.7 million, changed 0.0% from the prior year.
• Treasury Shares came in at $114.7 million for Q4 2021 at Tempest Therapeutics, roughly flat from $114.7 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $114.7 million in Q4 2020 to a low of $90.8 million in Q4 2017.
• Average Treasury Shares over 4 years is $98.8 million, with a median of $90.8 million recorded in 2017.
• Year-over-year, Treasury Shares soared 42.68% in 2017 and changed 0.0% in 2021.
• Over 4 years, Treasury Shares stood at $90.8 million in 2017, then changed by 0.0% to $90.8 million in 2018, then increased by 26.24% to $114.7 million in 2020, then changed by 0.0% to $114.7 million in 2021.
• Per Business Quant data, the three most recent Treasury Shares figures were $114.7 million in Q4 2021, $114.7 million in Q4 2020, and $90.8 million in Q3 2018.